Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty.

Berkowitz, S D; Marder, V J; Kosutic, G; Baughman, R A

Berkowitz, S D; Marder, V J; Kosutic, G; Baughman, R A.

Affiliation

Berkowitz SD; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

J Thromb Haemost ; 1(9): 1914-9, 2003 Sep.

Article in En | MEDLINE | ID: mdl-12941031

Subject(s)

Arthroplasty, Replacement, Hip/adverse effects; Drug Carriers; Heparin/administration & dosage; Thrombosis/prevention & control; Adolescent; Adult; Aged; Blood Transfusion; Caprylates; Factor Xa Inhibitors; Female; Hemorrhage/chemically induced; Heparin/adverse effects; Heparin/pharmacokinetics; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pharmacokinetics; Postoperative Care; Thrombosis/drug therapy

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thrombosis / Drug Carriers / Heparin / Arthroplasty, Replacement, Hip Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Year: 2003 Document type: Article

Search on Google

XML

PubMed Links